1Inhibition of tubulin detyrosination:a novel strategy to promote central nervous system regenerationCharlotte Zeitler，Marco Leibinger，Dietmar FischerPerspectives2557-2558
2Contribution of astrocytes to the neurovascular elimination of tauMaxwell Eisenbaum，Corbin BachmeierPerspectives2559-2560
3Structural changes in the obese brainAnna R.R.Da Conceicao，Marcelo N.N.Vieira，Fernanda G.De FelicePerspectives2561-2562
4Apoer2/Lrp8:the undercover cop of synaptic homeostasisGordon C.Werthmann，Joachim HerzPerspectives2563-2564
5Self-assembly of tau fragments as a key pathologic event in tauopathiesLv Thi Huong Luu Le，Jung Hoon Lee，Min Jae LeePerspectives2565-2566
6Glial progenitor heterogeneity and plasticity in the adult spinal cordHaichao Wei，Jia Qian WuPerspectives2567-2568
7Sex differences in Alzheimer's disease:an urgent research venue to followRaquel Jiménez-Herrera，Ana Contreras，Juan D.Navarro-López，Lydia Jiménez-DíazPerspectives2569-2570
8Oncostatin M:a love-hate relationship in neuroinflammationDoryssa Hermans，Niels Hellings，Bieke BrouxPerspectives2571-2572
9Microglial autophagy in neurogenesis:a new player in Alzheimer's diseaseXin Tang，Aarti Nagayach，Chenran WangPerspectives2573-2574
10A seed and soil model of loneliness in Alzheimer's diseaseHannah L.Apostolou，Ian M.McDonoughPerspectives2575-2576
11A novel approach to Parkinson's disease treatment with a potentially dual-acting therapeutic agent that targets α-synuclein aggregation and neuron deathAllison R.Balaj，Hiroaki KakuPerspectives2577-2578
12Molecular biomarkers for vascular cognitive impairment and dementia:the current status and directions for the futureSatoshi Hosoki，Perminder S.SachdevPerspectives2579-2580
13Strain-dependent alpha-synuclein spreading in Parkinson's disease and multiple system atrophyShuyu Zhang，Paul LingorPerspectives2581-2582
14Are we close to using Alzheimer blood biomarkers in clinical practice?Bruno P.Imbimbo，Simone Lista，Camillo Imbimbo，Robert NisticòPerspectives2583-2585
15Bone marrow-derived microglia confer neuroprotection to a mouse model of amyotrophic lateral sclerosisBeka SolomonPerspectives2586-2587
16A core scientific problem in the treatment of central nervous system diseases:newborn neuronsPeng Hao，Zhaoyang Yang，Kwok-Fai So，Xiaoguang LiReviews2588-2601
18A systematic review of salivary biomarkers in Parkinson's diseaseMaria Ilenia De Bartolo，Daniele Belvisi，Romina Mancinelli，Matteo Costanzo，Claudia Caturano，Giorgio Leodori，Alfredo Berardelli，Giovanni Fabbrini，Giorgio VivacquaReviews2613-2625
19Biomaterial engineering strategies for modeling the Bruch's membrane in age-related macular degenerationBlanca Molins，Andrea Rodríguez，Víctor Llorenç，Alfredo AdánReviews2626-2636
20Epileptic brain network mechanisms and neuroimaging techniques for the brain networkYi Guo，Zhonghua Lin，Zhen Fan，Xin TianReviews2637-2648
